rachial artery dimensions and reactivity as assessed by flow-mediated dilation (FMD) using ultrasound have been associated with cardiovascular disease.
B
rachial artery dimensions and reactivity as assessed by flow-mediated dilation (FMD) using ultrasound have been associated with cardiovascular disease. 1 Systematic analysis of common genetic variation and brachial artery reactivity may help explain the hereditary component of vascular function. 2 We performed an inverse variance weighting in a fixed effects meta-analysis of 6 genome-wide association studies on brachial artery diameter, maximum brachial artery diameter adjusted for baseline diameter, and FMD totaling 17 151 community-based individuals of European ancestry (Cardiovascular Health Study, Framingham Heart Study, GHS (Gutenberg Health Study), Prospective Investigation of the Vasculature in Uppsala Seniors, SHIP (Study of Health in Pomerania), and Young Finns Study). For replication, we genotyped up to 9555 independent individuals of the GHS using functionally tested standard 5´ nuclease assays on a 7900HT Fast Real-Time polymerase chain reaction system (Applied Biosystems). We selected 8 single nucleotide polymorphisms (SNPs; 6 for brachial artery diameter, 2 for maximum brachial artery diameter adjusted for baseline diameter, and 0 for FMD) with genome-wide significance or nominally significant regions with several supporting signals in the region and pathophysiological plausibility for replication by de novo genotyping in an independent GHS sample. Furthermore, we performed a stage 2 meta-analysis including all individuals. All studies were approved by the local ethics committees. Because of the sensitive nature of the data collected for this study, requests to access the dataset from qualified researchers trained in human subject confidentiality protocols may be sent to Dr med. Renate B. Schnabel at Department of General and Interventional Cardiology, University Heart Center Hamburg-Eppendorf, Germany.
The mean age of the study participants was 55 years, and ≈50% were women. We report 2 novel loci for baseline brachial artery diameter that replicated ( Figure  [A]) ; none of the SNPs chosen for replication were close to genome-wide significance in stage 1 meta-analysis for brachial artery diameter adjusted for baseline replicated (Figure [B] ), and no SNPs reached near genome-wide significance for the FMD phenotype in the discovery phase. The first one is an SNP rs924140 on chromosome 7 (minor allele frequency 0.43) in the IGFBP3 (insulin-like growth factor binding protein 3) gene, effect size beta per mm 0.033±0.006, P discovery =1.34×10 , for which we examined the replicated SNPs in relation to whole genome transcriptome data of circulating monocytes with RNA hybridized to Illumina HT-12 v3 BeadChips (Illumina Inc). Boxplots of expression intensity revealed a gradual decrease with a higher number of T alleles in monocytes and arterial tissues from different locations drawn from the GTEx Portal (gtexportal.org) for postmortem tissue (Figure [C] ). Further trans associations were observed for expression of BCAP29 (B-cell receptor-associated protein 29), chromosome 7, and the ZNF644 (zinc finger protein 644) in monocytes in the GHS. No monocyte gene expression signal was observed for the IGFBP3 gene locus.
IGFBP3 serves in the regulation of IGF-I (insulin-like growth factor I) concentrations and bioavailability. The circulating protein has been related to intima-media thickness and incident ischemic heart disease. 3 The genetic locus identified in relation to baseline brachial artery diameter in our study has been related to circulating IGFBP3 protein concentrations. 4 Thus, our results are in context with the literature, indicating a possible pathophysiological pathway from genetically determined IGFBP3 protein concentrations through vascular remodeling to cardiovascular disease and mortality. Whether modulation of such a speculative pathway may improve cardiovascular health needs to be evaluated.
The AS3MT-CNNM2 locus belongs to a gene-rich genomic region related to blood pressure phenotypes. The AS3MT-CNNM2 locus has been associated with coronary artery disease 5 and gene expression consistently across arterial tissue of different vascular beds. Long-term impact of elevated blood pressure may result in changes of the vascular wall that increase brachial artery dimensions and are correlated with coronary artery dysfunction and vulnerability to coronary artery disease.
Few genetic associations for FMD have been reported to date, most of which have not been replicated in independent samples, including initial genome-wide association study results. This observation is not unexpected because the heritability of FMD is low even in twin studies, indicating that the genetic component at the population level may not be strong. The low variability explained by genetics may suggest an important role of environment factors contributing to FMD variability. The clinical value of FMD may thus remain the ability to quantify vascular reactivity in the current state. 
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